Established in 2016, the Southeast Regional Center of Excellence in Vector-Borne Disease: The Gateway Program (SECVBD) will continue its work for another five years, thanks to renewed funding from the Centers for Disease Control and Prevention (CDC). “The center is a team effort to help communities prevent, prepare and respond to vector-borne disease threats through applied research and education efforts. We look forward to continuing to inform these public health actions,” said Rhoel Dinglasan, the center’s director and a professor in the University of Florida College of Veterinary Medicine affiliated with the UF Emerging Pathogens Institute.
The U.S. Centers for Disease Control and Prevention recently awarded a $10 million grant to a team led by Rhoel Dinglasan to test why are some countries in the grip of COVID-19 while others appear less affected.
University of Florida researcher Rhoel Dinglasan, Ph.D., was awarded $6 million by the Global Health Innovative Technology Fund to test a new malaria vaccine in people.